Fiscal year: 31/07	1999 (*)	2019	Variation
Turnover	17.1 M€	77.1 M€	+351%
Net Result	0.5 M€	-3.8 M€	NS
Market Capitalization	9.0 M€	21.4 M€ (**)	+138%
PER	18.0	NS
(*) Last fiscal year ended before the IPO (**) Base price on July 7th, 2020

I.B.I. advises EUROMEDIS since 1998 up to october 2016, as long as the Founding Family was the main shareholder of the Company.

Step 1: Listed on the OTC market on April 27th, 2000 for a value of € 9 million

• Capital increase of € 1.1 million
• Transfer of shares to the Public for € 0.5 million

Step 2: Transfer to the Euronext big board market on March 22, 2004 for a value of € 24.4 million

• Capital increase of € 3 million
• Transfer of shares to the Public for € 1.5 million

Step 3: Issue of convertible bonds on March 2005 for € 4.7 million

Step 4: Capital increase in July 2007 for € 6 million (14.7% stake) at a € 40.5 market capitalization. The family maintains a majority stake.

Step 5: Capital increase in april 2011 for € 2.8 million at a € 13.5 million € market capitalization.

Step 6: Take-over by a Family Office in January 2017.

25 acquisitions completed since the first listing on the OTC in 2000 on a total of 32 since Euromedis inception.

• 1 bond of € 2.8 M was launched in 2019
• 245 employees at December 31, 2019

Transferred to Euronext Growth at September 23, 2020.